Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Publication of UY28850A1publicationCriticalpatent/UY28850A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La invención proporciona compuestos de fórmula (I): o profármacos de los mismos o sales farmacéuticamente aceptables de dichos compuestos o profármacos o solvatos de dichos compuestos, profármacos o sales, en los que A, N, X y R1 son como se definió en la presente memoria, composiciones farmacéuticas de los mismos; útiles para el tratamiento de la diabetes y enfermedades que están asociadas con proteínas que están sometidas a un procedimiento por DPP-IV.The invention provides compounds of formula (I): or prodrugs thereof or pharmaceutically acceptable salts of said compounds or prodrugs or solvates of said compounds, prodrugs or salts, wherein A, N, X and R1 are as defined in the present report, pharmaceutical compositions thereof; useful for the treatment of diabetes and diseases that are associated with proteins that are subjected to a DPP-IV procedure.
UY28850A2004-04-142005-04-12
INHIBITORS OF DIPEPTIDIL PEPTIDASA IV
UY28850A1
(en)
Compounds derived from pyrrolidin-2-carboxamide, p53-mdm2 interaction inhibitors; pharmaceutical composition that includes them; and its use in the preparation of useful medicines for the treatment of cancer.